+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Africa Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By Category, By Indication, By Product Stage, By Service Provider, By Company Size, By Country, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • September 2023
  • Region: Africa
  • Grand View Research
  • ID: 5893166
Description Jump to:
The Africa pharmaceutical regulatory affairs market size is expected to reach USD 213.06 million by 2030, registering a CAGR of 6.81% from 2023 to 2030. The market is driven by increasing demand for pharmaceutical products across the Africa region coupled with the growing need for safe and effective drugs, which requires stringent regulatory oversight. Moreover, the rise in the prevalence of various diseases, including communicable and non-communicable diseases, propels the demand for pharmaceuticals.

The COVID-19 pandemic had a significant impact on the market. The pandemic highlighted the importance of a robust regulatory framework to expedite the approval process for important drugs and vaccines, and African regulatory authorities responded by streamlining emergency authorization procedures. Moreover, COVID-19 emphasized the importance of strengthening pharmaceutical manufacturing capabilities within the region. Several countries have reduced their dependence on imports and are now investing in local production to enhance supply chain resilience. These factors have contributed to market growth.

The increasing number of clinical trials conducted in Africa is impacting the regulatory landscape. Many global pharmaceutical companies are conducting trials in the region due to the diverse patient populations and lower costs. As a result, stringent regulatory oversight is essential to safeguarding trial participants and ensuring the validity of research outcomes, bolstering the role of regulatory affairs. Moreover, the ongoing efforts to improve healthcare access and infrastructure in Africa are driving the demand for pharmaceutical products. As healthcare systems continue to evolve, regulatory affairs play an important role in assuring the quality and efficacy of medicines, thus driving the market growth.

Africa Pharmaceutical Regulatory Affairs Market Report Highlights

  • By services, the regulatory writing & publishing segment dominated the market with a share of over 36% in 2022. The legal representation segment is projected to witness the fastest growth rate in the coming years
  • By category, the drugs segment dominated the market in 2022. Regulatory affairs play a very important role in the entire drug development, manufacturing, and commercialization continuum
  • By indication, the oncology segment held the highest share of the market in 2022. This can be attributed to the high prevalence of cancer, which is boosting the need for safe and effective treatment options
  • By product stage, the clinical studies segment held the highest share of the market in 2022. This can be attributed to the increasing number of clinical trial registrations over the past few years
  • By service provider, the outsourcing segment dominated the market in 2022. This can be attributed to the increasing popularity of these services as outsourcing enables healthcare companies to reduce costs and prioritize strategic projects
  • By company size, the medium segment dominated the market in 2022. These companies have a broader product portfolio and a wider geographic presence, allowing them to serve a larger customer base across different African countries

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Africa Pharmaceutical Regulatory Affairs Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Changing regulatory landscape
3.2.1.2. Life sciences companies focus on their core competencies.
3.2.1.3. Economic and competitive pressures
3.2.1.4. Demand for faster approval process for breakthrough drugs and devices
3.2.1.5. Entry of companies into the global market
3.2.1.6. Growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs
3.2.2. Market Restraint Analysis
3.2.2.1. Risk associated with data security.
3.2.2.2. Monitoring issues and lack of standardization
3.3. Africa Pharmaceutical Regulatory Affairs Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.3. COVID-19 Impact Analysis
3.3.4. Service Gap Analysis
3.3.4.1. Market Opportunities
3.3.4.2. Market Challenges
3.3.5. Africa Market Composition
3.3.6. Qualitative Analysis of Primary Factors Driving Market Demand for Pharmaceutical Products and Healthcare Services across the African Countries
Chapter 4. Africa Pharmaceutical Regulatory Affairs Market: Services Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Africa Pharmaceutical Regulatory Affairs Market: Services Movement Analysis & Market Share, 2022 & 2030
4.3. Regulatory Consulting
4.3.1. Regulatory Consulting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Legal Representation
4.4.1. Legal Representation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Regulatory Writing & Publishing
4.5.1. Regulatory Writing & Publishing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Writing
4.5.2.1. Writing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Publishing
4.5.3.1. Publishing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Product Registration & Clinical Trial Applications
4.6.1. Product Registration & Clinical Trial Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Other Services
4.7.1. Other Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Africa Pharmaceutical Regulatory Affairs Market: Category Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Africa Pharmaceutical Regulatory Affairs Market: Category Movement Analysis & Market Share, 2022 & 2030
5.3. Drugs
5.3.1. Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Innovator
5.3.2.1. Innovator Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.2. Preclinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.3. Clinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2.4. Pre-Market Approval (PMA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Generics
5.3.3.1. Generics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3.2. Preclinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3.3. Clinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3.4. Pre-Market Approval (PMA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Biologics
5.4.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Biotech
5.4.2.1. Biotech Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2.2. Preclinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2.3. Clinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2.4. Pre-Market Approval (PMA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. ATMP
5.4.3.1. ATMP Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3.2. Preclinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3.3. Clinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3.4. Pre-Market Approval (PMA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. Biosimilars
5.4.4.1. Biosimilars Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4.2. Preclinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4.3. Clinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4.4. Pre-Market Approval (PMA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Africa Pharmaceutical Regulatory Affairs Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Africa Pharmaceutical Regulatory Affairs Market: Indication Movement Analysis & Market Share, 2022 & 2030
6.3. Oncology
6.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Neurology
6.4.1. Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Cardiology
6.5.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Immunology
6.6.1. Immunology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Africa Pharmaceutical Regulatory Affairs Market: Product Stage Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Africa Pharmaceutical Regulatory Affairs Market: Product Stage Movement Analysis & Market Share, 2022 & 2030
7.3. Preclinical
7.3.1. Preclinical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Clinical studies
7.4.1. Clinical studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. PMA
7.5.1. PMA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Africa Pharmaceutical Regulatory Affairs Market: Service Provider Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Africa Pharmaceutical Regulatory Affairs Market: Service Provider Movement Analysis & Market Share, 2022 & 2030
8.3. In-house
8.3.1. In-house Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Outsourcing
8.4.1. Outsourcing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Africa Pharmaceutical Regulatory Affairs Market: Company Size Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Africa Pharmaceutical Regulatory Affairs Market: Company Size Movement Analysis & Market Share, 2022 & 2030
9.3. Small
9.3.1. Small Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Medium
9.4.1. Medium Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Large
9.5.1. Large Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Africa Pharmaceutical Regulatory Affairs Market: Regional Estimates & Trend Analysis
10.1. Regional Outlook
10.2. Africa Pharmaceutical Regulatory Affairs Market: Regional Movement Analysis & Market Share, 2022 & 2030
10.2.1. South Africa
10.2.1.1. Key Country Dynamics
10.2.1.2. Competitive Scenario
10.2.1.3. Regulatory Framework
10.2.1.4. South Africa Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.2. Botswana
10.2.2.1. Key Country Dynamics
10.2.2.2. Competitive Scenario
10.2.2.3. Regulatory Framework
10.2.2.4. Botswana Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.3. Namibia
10.2.3.1. Key Country Dynamics
10.2.3.2. Competitive Scenario
10.2.3.3. Regulatory Framework
10.2.3.4. Namibia Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.4. Zimbabwe
10.2.4.1. Key Country Dynamics
10.2.4.2. Competitive Scenario
10.2.4.3. Regulatory Framework
10.2.4.4. Zimbabwe Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.5. Zambia
10.2.5.1. Key Country Dynamics
10.2.5.2. Competitive Scenario
10.2.5.3. Regulatory Framework
10.2.5.4. Zambia Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.6. Tanzania
10.2.6.1. Key Country Dynamics
10.2.6.2. Competitive Scenario
10.2.6.3. Regulatory Framework
10.2.6.4. Tanzania Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.7. Rwanda
10.2.7.1. Key Country Dynamics
10.2.7.2. Competitive Scenario
10.2.7.3. Regulatory Framework
10.2.7.4. Rwanda Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.8. Ghana
10.2.8.1. Key Country Dynamics
10.2.8.2. Competitive Scenario
10.2.8.3. Regulatory Framework
10.2.8.4. Ghana Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.9. Nigeria
10.2.9.1. Key Country Dynamics
10.2.9.2. Competitive Scenario
10.2.9.3. Regulatory Framework
10.2.9.4. Nigeria Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.10. Uganda
10.2.10.1. Key Country Dynamics
10.2.10.2. Competitive Scenario
10.2.10.3. Regulatory Framework
10.2.10.4. Uganda Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.11. Mauritius
10.2.11.1. Key Country Dynamics
10.2.11.2. Competitive Scenario
10.2.11.3. Regulatory Framework
10.2.11.4. Mauritius Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.12. Kenya
10.2.12.1. Key Country Dynamics
10.2.12.2. Competitive Scenario
10.2.12.3. Regulatory Framework
10.2.12.4. Kenya Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
10.2.13. Rest of Africa
10.2.13.1. Key Country Dynamics
10.2.13.2. Competitive Scenario
10.2.13.3. Regulatory Framework
10.2.13.4. Rest of Africa Pharmaceutical Regulatory Affairs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 11. Competitive Landscape
11.1. Key Company Profiles
11.1.1. Participant’s Overview
11.1.2. Product/ Software & Services Benchmarking
11.1.3. Financial Performance
11.1.4. Strategic Initiatives
11.1.4.1 Freyr
11.1.4.2 IQVIA Inc
11.1.4.3 ICON plc
11.1.4.4 WuXi AppTec
11.1.4.5 Charles River Laboratories
11.1.4.6 Labcorp Drug Development
11.1.4.7 Parexel International Corporation
11.1.4.8 Pharmalex GmbH
11.1.4.9 Pharmexon
11.1.4.10 Genpact
11.2. Participant Categorization
11.3. Heat Map Analysis/ Company Market Position Analysis
11.4. Strategy Mapping
11.5. List of Other Key Market Players
List of Tables
Table 1.
Table 2. List of Secondary Sources
Table 3. List of Abbreviations
Table 4. Africa Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 5. Africa Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 6. Africa Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 7. Africa Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 8. Africa Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 9. Africa Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 10. South Africa Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 11. South Africa Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 12. South Africa Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 13. South Africa Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 14. South Africa Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 15. South Africa Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 16. Botswana Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 17. Botswana Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 18. Botswana Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 19. Botswana Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 20. Botswana Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 21. Botswana Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 22. Namibia Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 23. Namibia Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 24. Namibia Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 25. Namibia Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 26. Namibia Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 27. Namibia Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 28. Zimbabwe Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 29. Zimbabwe Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 30. Zimbabwe Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 31. Zimbabwe Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 32. Zimbabwe Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 33. Zimbabwe Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 34. Zambia Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 35. Zambia Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 36. Zambia Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 37. Zambia Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 38. Zambia Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 39. Zambia Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 40. Tanzania Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 41. Tanzania Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 42. Tanzania Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 43. Tanzania Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 44. Tanzania Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 45. Tanzania Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 46. Rwanda Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 47. Rwanda Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 48. Rwanda Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 49. Rwanda Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 50. Rwanda Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 51. Rwanda Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 52. Ghana Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 53. Ghana Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 54. Ghana Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 55. Ghana Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 56. Ghana Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 57. Ghana Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 58. Nigeria Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 59. Nigeria Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 60. Nigeria Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 61. Nigeria Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 62. Nigeria Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 63. Nigeria Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 64. Uganda Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 65. Uganda Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 66. Uganda Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 67. Uganda Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 68. Uganda Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 69. Uganda Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 70. Mauritius Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 71. Mauritius Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 72. Mauritius Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 73. Mauritius Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 74. Mauritius Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 75. Mauritius Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 76. Kenya Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 77. Kenya Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 78. Kenya Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 79. Kenya Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 80. Kenya Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 81. Kenya Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 82. Algeria Pharmaceutical Regulatory Affairs Market, by Services, 2018 - 2030 (USD Million)
Table 83. Algeria Pharmaceutical Regulatory Affairs Market, by Category, 2018 - 2030 (USD Million)
Table 84. Algeria Pharmaceutical Regulatory Affairs Market, by Indication, 2018 - 2030 (USD Million)
Table 85. Algeria Pharmaceutical Regulatory Affairs Market, by Product Stage, 2018 - 2030 (USD Million)
Table 86. Algeria Pharmaceutical Regulatory Affairs Market, by Service Provider, 2018 - 2030 (USD Million)
Table 87. Algeria Pharmaceutical Regulatory Affairs Market, by Company Size, 2018 - 2030 (USD Million)
Table 88. Participant’s overview
Table 89. Financial performance
Table 90. Product/ Software & Services benchmarking
Table 91. Strategic Initiatives
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value chain - based sizing & forecasting
Fig. 6 QFD modelling for market share assessment.
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Africa Pharmaceutical Regulatory Affairs Market: Services Movement Analysis
Fig. 10 Africa Pharmaceutical Regulatory Affairs Market, for Regulatory Consulting, 2018 - 2030 (USD Million)
Fig. 11 Africa Pharmaceutical Regulatory Affairs Market, for Legal Representation , 2018 - 2030 (USD Million)
Fig. 12 Africa Pharmaceutical Regulatory Affairs Market, for Regulatory Writing & Publishing, 2018 - 2030 (USD Million)
Fig. 13 Africa Pharmaceutical Regulatory Affairs Market, for Writing
Fig. 14 Africa Pharmaceutical Regulatory Affairs Market, for Publishing
Fig. 15 Africa Pharmaceutical Regulatory Affairs Market, for Product Registration & Clinical Trial Applications, 2018 - 2030 (USD Million)
Fig. 16 Africa Pharmaceutical Regulatory Affairs Market, for Other Services
Fig. 17 Africa Pharmaceutical Regulatory Affairs Market: Category Movement Analysis
Fig. 18 Africa Pharmaceutical Regulatory Affairs Market, for Drugs, 2018 - 2030 (USD Million)
Fig. 19 Africa Pharmaceutical Regulatory Affairs Market, for Innovator
Fig. 20 Africa Pharmaceutical Regulatory Affairs Market, for Preclinical
Fig. 21 Africa Pharmaceutical Regulatory Affairs Market, for Clinical
Fig. 22 Africa Pharmaceutical Regulatory Affairs Market, for Pre - Market Approval (PMA)
Fig. 23 Africa Pharmaceutical Regulatory Affairs Market, for Generics
Fig. 24 Africa Pharmaceutical Regulatory Affairs Market, for Preclinical
Fig. 25 Africa Pharmaceutical Regulatory Affairs Market, for Clinical
Fig. 26 Africa Pharmaceutical Regulatory Affairs Market, for Pre - Market Approval (PMA)
Fig. 27 Africa Pharmaceutical Regulatory Affairs Market, for Biologics, 2018 - 2030 (USD Million)
Fig. 28 Africa Pharmaceutical Regulatory Affairs Market, for Biotech
Fig. 29 Africa Pharmaceutical Regulatory Affairs Market, for Preclinical
Fig. 30 Africa Pharmaceutical Regulatory Affairs Market, for Clinical
Fig. 31 Africa Pharmaceutical Regulatory Affairs Market, for Pre - Market Approval (PMA)
Fig. 32 Africa Pharmaceutical Regulatory Affairs Market, for ATMP
Fig. 33 Africa Pharmaceutical Regulatory Affairs Market, for Preclinical
Fig. 34 Africa Pharmaceutical Regulatory Affairs Market, for Clinical
Fig. 35 Africa Pharmaceutical Regulatory Affairs Market, for Pre - Market Approval (PMA)
Fig. 36 Africa Pharmaceutical Regulatory Affairs Market, for Biosimilars
Fig. 37 Africa Pharmaceutical Regulatory Affairs Market, for Preclinical
Fig. 38 Africa Pharmaceutical Regulatory Affairs Market, for Clinical
Fig. 39 Africa Pharmaceutical Regulatory Affairs Market, for Pre - Market Approval (PMA)
Fig. 40 Africa Pharmaceutical Regulatory Affairs Market: Indication Movement Analysis
Fig. 41 Africa Pharmaceutical Regulatory Affairs Market, for Oncology, 2018 - 2030 (USD Million)
Fig. 42 Africa Pharmaceutical Regulatory Affairs Market, for Neurology, 2018 - 2030 (USD Million)
Fig. 43 Africa Pharmaceutical Regulatory Affairs Market, for Cardiology, 2018 - 2030 (USD Million)
Fig. 44 Africa Pharmaceutical Regulatory Affairs Market, for Immunology, 2018 - 2030 (USD Million)
Fig. 45 Africa Pharmaceutical Regulatory Affairs Market, for Others, 2018 - 2030 (USD Million)
Fig. 46 Africa Pharmaceutical Regulatory Affairs Market: Product Stage, 2018 - 2030 (USD Million)
Fig. 47 Africa Pharmaceutical Regulatory Affairs Market, for Preclinical, 2018 - 2030 (USD Million)
Fig. 48 Africa Pharmaceutical Regulatory Affairs Market, for Clinical studies, 2018 - 2030 (USD Million)
Fig. 49 Africa Pharmaceutical Regulatory Affairs Market, for PMA, 2018 - 2030 (USD Million)
Fig. 50 Africa Pharmaceutical Regulatory Affairs Market: Service Provider, 2018 - 2030 (USD Million)
Fig. 51 Africa Pharmaceutical Regulatory Affairs Market, for In - house, 2018 - 2030 (USD Million)
Fig. 52 Africa Pharmaceutical Regulatory Affairs Market, for Outsourcing, 2018 - 2030 (USD Million)
Fig. 53 Africa Pharmaceutical Regulatory Affairs Market: Company Size, 2018 - 2030 (USD Million)
Fig. 54 Africa Pharmaceutical Regulatory Affairs Market, for Small, 2018 - 2030 (USD Million)
Fig. 55 Africa Pharmaceutical Regulatory Affairs Market, for Medium, 2018 - 2030 (USD Million)
Fig. 56 Africa Pharmaceutical Regulatory Affairs Market, for Large, 2018 - 2030 (USD Million)
Fig. 57 Country Marketplace: Key Takeaways
Fig. 58 Country Outlook, 2022 & 2030
Fig. 59 Africa Pharmaceutical Regulatory Affairs Market: Country Movement Analysis
Fig. 60 South Africa Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 61 Botswana Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 62 Namibia Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 63 Zimbabwe Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 64 Zambia Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 65 Tanzania Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 66 Rwanda Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 67 Ghana Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 68 Nigeria Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 69 Uganda Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 70 Mauritius Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)
Fig. 71 Kenya Pharmaceutical Regulatory Affairs Market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Freyr
  • IQVIA Inc
  • ICON plc
  • WuXi AppTec
  • Charles River Laboratories
  • Labcorp Drug Development
  • Parexel International Corporation
  • Pharmalex GmbH
  • Pharmexon
  • Genpact

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 126.04 Million
Forecasted Market Value ( USD ) by 2030 $ 213.06 Million
Compound Annual Growth Rate6.8%
Regions CoveredAfrica
No. of Companies Mentioned10

Related Topics

Related Reports

Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service Provider, By Service, By Category, By Indication, By Development Stage, By Company Size, By Region, and Segment Forecasts, 2024 - 2030 - Product Image

Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service Provider, By Service, By Category, By Indication, By Development Stage, By Company Size, By Region, and Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Pharmaceutical Regulatory Affairs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Image

Pharmaceutical Regulatory Affairs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • 110 Pages
  • Global
From
Nonclinical Safety Assessment. A Guide to International Pharmaceutical Regulations. Edition No. 1 - Product Image

Nonclinical Safety Assessment. A Guide to International Pharmaceutical Regulations. Edition No. 1

  • Book
  • 488 Pages
  • Global
FDA Regulatory Compliance for Drug and Biotech Product Training Course (December 2-3, 2024) - Product Image

FDA Regulatory Compliance for Drug and Biotech Product Training Course (December 2-3, 2024)

  • Training
  • 2 Days
  • Global
From
FDA Regulatory Compliance for Drug and Biotech Product Training Course (Recorded) - Product Image

FDA Regulatory Compliance for Drug and Biotech Product Training Course (Recorded)

  • Training
  • 2 Days
  • Global
From

About the Pharmaceutical Regulation Market

The Pharmaceutical Regulation market is a sector of the pharmaceutical industry that focuses on the regulation of drugs and other related products. It is responsible for ensuring that drugs are safe and effective for use by the public. This includes the evaluation of clinical trials, the approval of new drugs, and the monitoring of drug safety and efficacy. The market also includes the enforcement of regulations and the enforcement of intellectual property rights. The Pharmaceutical Regulation market is composed of a variety of stakeholders, including pharmaceutical companies, regulatory authorities, and research institutions. Pharmaceutical companies are responsible for the development and production of drugs, while regulatory authorities are responsible for the approval and monitoring of drugs. Research institutions are responsible for conducting clinical trials and providing data to regulatory authorities. Some of the major companies in the Pharmaceutical Regulation market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.